Whole Genome and Exome Sequencing Markets by Research, Clinical, Direct to Consumer, AgriBio & Tumor Including Test Price and Volume Forecasts with Executive and Consultant Guides 2018 to 2022

  • ID: 4580197
  • Report
  • Region: Global
  • 339 Pages
  • Howe Sound Research
1 of 5
Whole Genome Sequencing Costs Plummet. Industry on Verge of Mainstream Breakout into Healthcare, Consumer and Agricultural Markets.

FEATURED COMPANIES

  • 10X Genomics
  • Centogene
  • Gene by Gene Ltd
  • Helix
  • MNG Labs
  • Personalis
  • MORE

Will all newborns receive Whole Genome Sequencing at birth?  How fast will Direct to Consumer Testing grow?  What sequencing technology will take the lead? What’s holding the industry back?  Where are the over 800 locations that have high throughput devices?
Our facts and support = Your success.

A plummeting of costs for Whole Genome Sequencing is creating a gold rush for market players.  New consumers, new technologies, new specializations. In a situation reminiscent of the birth of the internet industry a wide range of well funded players are racing for market share on a truly global stage.  The report forecasts the market size out to 2023.  The report includes detailed breakouts for 14 countries and 5 regions.

Tumor Cell Sequencing? Direct to Consumer? Gene Expression? Find out about the technology in readily understood terms that explain the jargon.  What are the issues?  Find the opportunities, and the pitfalls.  Understand growth expectations and the ultimate market forecasts for the next five years.

Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 10X Genomics
  • Centogene
  • Gene by Gene Ltd
  • Helix
  • MNG Labs
  • Personalis
  • MORE

1. Introduction and Market Definition
1.1 Whole Genome Sequencing Definition In This Report
1.1.1 Whole and Exome Sequencing
1.1.2 Research and Clinical
1.1.3 Direct to Consumer
1.1.4 AgriBio
1.1.5 Tumor Cells
1.2 The Genomics Revolution
1.3 Market Definition
1.3.1 Volumes
1.3.2 Prices
1.3.3 Revenue Market Size
1.4 U.S. Medical Market and laboratory Testing - Perspective
1.4.1 U.S. Medicare Expenditures for laboratory testing
1.5 Sizing the Genome – Not What You Think
1.5.1 Cost, Price and Genome Size, Pricing Practice
1A GLOBAL LISTING OF HIGH THROUGHPUT SEQUENCING ESTABLISHMENTS
INSTALLED BASE – Location & Contacts

2. Market Overview
2.1 Market Participants Play Different Roles
2.1.1 Instrument Manufacturer
2.1.2 Independent lab specialized/esoteric
2.1.3 Independent lab national/regional
2.1.4 Independent lab analytical
2.1.5 Public National/regional lab
2.1.6 Hospital lab
2.1.7 Physician lab
2.1.8 DTC Lab
2.1.9 Sequencing Labs
2.1.10 Audit body
2.2 Whole Genome Sequencing –Markets, Examples and Discussion
2.2.1 Direct to Consumer – Two Approaches
2.2.1.1 The New Age of Medical Information
2.2.1.2 Dangers in  DTC-WGS – Health Costs and Regulation
2.2.1.3 Newborn and Prenatal – A Brave New World
2.2.1.4 DTC – How Many Segments?
2.2.2 Research Markets
2.2.2.1  Research Funding and Capital Expense
2.2.2.2  WGS Datasets Preferred
2.2.2.3  Existing research repurposed
2.2.2.4  Organism Wide Market
2.2.2.5  Service Suppliers Respond
2.2.3 Clinical – Understanding Germline and Somatic
2.2.3.1 Somatic – Chasing Mutations and Pharmacogenomics
2.2.4 Pathogen Testing
2.2.4.1 The Hepatitis C Story
2.2.4.2 Will the Microbiology Department Disappear?
2.2.5 AgriBio – Big Business
2.2.5.1 GMO is Here to Stay
2.2.5.2 WGS Benefits and Risks
2.2.5.3 The New Agriculture
2.3 Industry Structure
2.3.1 Hospital’s Testing Share
2.3.2 Economies of Scale
2.3.3 Instrument Manufacturer Role
2.3.4 Healthcare Industry Impacts – Still Struggling
2.3.4.1 Can the Healthcare Industry Adapt?
2.3.4.2 Genetic Counselling as an Industry
2.3.4.3 WGES Adoption and Cannibalization
2.3.4.4 The Meaning of Grail
2.4 Profiles of Key Companies
2.4.1 Roche Molecular Diagnostics
2.4.2 Illumina
2.4.3 Grail
2.4.4 Complete Genomics - BGI
2.4.5 Qiagen
2.4.6 GE Global Research
2.4.7 BGI Genomics Co. Ltd.
2.4.8 Oxford Nanopore Technologies
2.4.9 Genomic Health
2.4.10 Pacific Biosciences
2.4.11 Siemens Healthcare
2.4.12 23 and Me
2.4.13 Ancestry.com
2.4.14 Bio-Rad
2.4.15 Thermo Fisher
2.4.16 Fabric Genomics
2.4.17 Centogene
2.4.18 Gene by Gene Ltd
2.4.19 Veritas Genetics
2.4.20 Dante Labs
2.4.21 Guardiome
2.4.22 Sure Genomics
2.4.23 Novogene
2.4.24 Helix
2.4.25 Genomics Personalized Health (GPH)
2.4.26 Sequencing.com
2.4.27 Omega Bioservices
2.4.28 ORIG3N
2.4.29 Human Longevity, Inc.
2.4.30 Invitae
2.4.31 MNG Labs
2.4.32 Regeneron
2.4.33 Medgenome
2.4.34 10X Genomics
2.4.35 Genomics England
2.4.36 Stratos Genomics
2.4.37 Personalis
2.4.38 Perkin Elmer
2.4.39 Macrogen
2.4.40 Gencove
2.4.41 Genewiz
2.4.42 Agilent Technologies

3. Market Trends
3.1 Factors Driving Growth
3.1.1 Diagnostic Factors
3.1.2 Interpreting the Code Otherwise
3.1.3 Changes in Agriculture
3.1.4 Fertility Technology Comes of Age
3.1.5 Pathogen Challenges
3.2 Factors Limiting Growth
3.2.1 Increased Competition Lowers Price
3.2.2 Lower Costs
3.2.3 Healthcare Cost Concerns Curtail Growth
3.2.4 Wellness has a downside
3.2.5 GMO Opposition Movement
3.3 Sequencing Instrumentation
3.3.1 Instrumentation Tenacity
3.3.2 Declining Cost of Instruments Changes Industry Structure.
3.3.3 LISTING of CURRENT INSTRUMENT SPECIFICATIONS
3.3.4 Long Reads – Further Segmentation
3.3.5 Linked Reads
3.3.6  New Sequencing Technologies

4. WGES Recent Developments
4.1 Recent Developments – Importance and How to Use This Section
4.1.1 Importance of These Developments
4.1.2 How to Use This Section
4.2 Rapid genome sequencing could revolutionize health care
4.3 Human Longevity Launches Whole Genome Product, MassMutual Partnerships
4.4 Influence of Whole Genome Sequencing growing
4.5 Rady Children's and Edico Genome Extend WGS Collaboration
4.6 $1500 to sequence newborns in China
4.7 Newborns to Get Whole Genome Sequencing
4.8 Eurofins Acquiring PerkinElmer’s NTD Laboratory Services Business
4.9 Konica Minolta to buy Ambry Genetics, deal worth up to $1 billion
4.10 AstraZeneca taps gene pioneer Venter for huge drug-hunting sweep
4.11 The Cooper Companies’ Women’s Health Care Unit Acquires Genesis Genetics
4.12 Research Validates Preimplantation Genetic Diagnosis for Aneuploidy (PGD-A)
4.13 New Investments in Ancestry.com to Boost DNA Business
4.14 GHO Capital Announces Acquisition of DNA Diagnostics Center
4.15 PerkinElmer Launches Clinical Whole Genome Sequencing Services
4.16 WGS and AI help clinicians scale precision oncology
4.17  Veritas Genetics Buys Curoverse
4.18  Dante Labs Partners With Amazon UK for Special £349 Whole Genome Sequencing
4.19 Toolbox Genomics Launches Personalized Wellness App in Sequencing.com's Revolutionary App Market
4.20 CDC invests in WGS to help states respond to infectious disease threats
4.21 Factory contamination of medical device likely source of M. chimaera infection in patients in multiple countries
4.22 IBM Watson impresses in WGS brain tumour analysis
4.23  OneOme, Genome.One Partner to Offer Genetic Risk, PGx Service in Australia
4.24  WGS aids in Salmonella outbreak control
4.25 CombiMatrix In Merger Agreement with Invitae to be Acquired for $33 Million in Invitae Common Stock
4.26  Nine Centres use Oxford Nanopore MinION to Sequence Human Genome 
4.27 Esperite and BGI Genomics sign a strategic agreement to offer Whole Genome Sequencing on a large scale
4.28  Easily Affordable Whole-genome Sequencing is Goal of Mayo Collaboration with Veritas 
4.29  Regeneron Partners With AbbVie, Alnylam, AstraZeneca, Biogen, Pfizer to Sequence UK Biobank Samples
4.30 MedGenome Expands Its NGS Capabilities and Forays Into Single-Cell Sequencing
4.31 Genomics England Adopts Edico's Dragen For NGS Analysis
4.32 BGI Says It Will Slash Cost of Gene Testing to $300
4.33 Position Statement Spells Out Fetal Diagnostic Sequencing Recommendations
4.34 Stratos Genomics Raises Funds to Ready for Commercialization
4.35 Whole genome sequencing identifies new genetic signature for autism
4.36  Inova, Veritas Genetics Partner to Offer Whole-Genome Sequencing, Interpretation
4.37  Dante Labs Announces 10,000 European Genome Project
4.38 PerkinElmer Extends Clinical Whole Genome Sequencing Services
4.39 Personalis Signs New Genome Sequencing Services Contract With VA
4.40  Dante Labs Offers EUR 850 Whole Genome Sequencing and Interpretation
4.41 NorthShore Enlists Ambry Genetics for Whole-Exome Sequencing

5.  Country Market Sizes – North America
5.1 United States of America
5.1.1 Research – Volumes, Prices, Revenues
5.1.2 Clinical – Volumes, Prices, Revenues
5.1.3 AgriBio – Volumes, Prices, Revenues
5.1.4 Direct to Consumer Testing – Volumes, Prices, Revenues
5.1.5 Tumor – Volumes, Prices, Revenues
5.2 Canada
5.2.1 Research – Volumes, Prices, Revenues
5.2.2 Clinical  – Volumes, Prices, Revenues
5.2.3 AgriBio – Volumes, Prices, Revenues
5.2.4 Direct to Consumer Testing – Volumes, Prices, Revenues
5.2.5 Tumor – Volumes, Prices, Revenues

6. Country Markets – Europe
6.1 France
6.1.1 Research – Volumes, Prices, Revenues
6.1.2 Clinical  – Volumes, Prices, Revenues
6.1.3 AgriBio – Volumes, Prices, Revenues
6.1.4 Direct to Consumer Testing – Volumes, Prices, Revenues
6.1.5 Tumor – Volumes, Prices, Revenues
6.2 Germany
6.2.1 Research – Volumes, Prices, Revenues
6.2.2 Clinical  – Volumes, Prices, Revenues
6.2.3 AgriBio – Volumes, Prices, Revenues
6.2.4 Direct to Consumer Testing – Volumes, Prices, Revenues
6.2.5 Tumor – Volumes, Prices, Revenues
6.3 United Kingdom
6.3.1 Research – Volumes, Prices, Revenues
6.3.2 Clinical  – Volumes, Prices, Revenues
6.3.3 AgriBio – Volumes, Prices, Revenues
6.3.4 Direct to Consumer Testing – Volumes, Prices, Revenues
6.3.5 Tumor– Volumes, Prices, Revenues
6.4 Spain
6.4.1 Research – Volumes, Prices, Revenues
6.4.2 Clinical  – Volumes, Prices, Revenues
6.4.3 AgriBio – Volumes, Prices, Revenues
6.4.4 Direct to Consumer Testing – Volumes, Prices, Revenues
6.4.5 Tumor – Volumes, Prices, Revenues
6.5 Italy
6.5.1 Research – Volumes, Prices, Revenues
6.5.2 Clinical  – Volumes, Prices, Revenues
6.5.3 AgriBio – Volumes, Prices, Revenues
6.5.4 Direct to Consumer Testing – Volumes, Prices, Revenues
6.5.5 Tumor – Volumes, Prices, Revenues
6.6 Russia
6.6.1 Research – Volumes, Prices, Revenues
6.6.2 Clinical  – Volumes, Prices, Revenues
6.6.3 AgriBio Testing – Volumes, Prices, Revenues
6.6.4 Direct to Consumer Testing – Volumes, Prices, Revenues
6.6.5 Tumor – Volumes, Prices, Revenues
6.7 Remainder of Europe and Former Soviet Union
6.7.1 Research – Volumes, Prices, Revenues
6.7.2 Clinical  – Volumes, Prices, Revenues
6.7.3 AgriBio – Volumes, Prices, Revenues
6.7.4 Direct to Consumer Testing – Volumes, Prices, Revenues
6.7.5 Tumor – Volumes, Prices, Revenues

7. Country Markets – Asia Pacific
7.1 China
7.1.1 Research – Volumes, Prices, Revenues
7.1.2 Clinical  – Volumes, Prices, Revenues
7.1.3 AgriBio – Volumes, Prices, Revenues
7.1.4 Direct to Consumer Testing – Volumes, Prices, Revenues
7.1.5 Tumor – Volumes, Prices, Revenues
7.2 Japan
7.2.1 Research – Volumes, Prices, Revenues
7.2.2 Clinical  – Volumes, Prices, Revenues
7.2.3 AgriBio – Volumes, Prices, Revenues
7.2.4 Direct to Consumer Testing – Volumes, Prices, Revenues
7.2.5 Tumor – Volumes, Prices, Revenues
7.3 South Korea
7.3.1 Research – Volumes, Prices, Revenues
7.3.2 Clinical  – Volumes, Prices, Revenues
7.3.3 AgriBio – Volumes, Prices, Revenues
7.3.4 Direct to Consumer Testing – Volumes, Prices, Revenues
7.3.5 Tumor – Volumes, Prices, Revenues
7.4 India
7.4.1 Research – Volumes, Prices, Revenues
7.4.2 Clinical  – Volumes, Prices, Revenues
5.1.3 AgriBio – Volumes, Prices, Revenues
7.4.4 Direct to Consumer Testing – Volumes, Prices, Revenues
7.4.5 Tumor – Volumes, Prices, Revenues
7.5 Australia
7.5.1 Research – Volumes, Prices, Revenues
7.5.2 Clinical  – Volumes, Prices, Revenues
7.5.3 AgriBio  – Volumes, Prices, Revenues
7.5.4 Direct to Consumer Testing – Volumes, Prices, Revenues
7.5.5 Tumor – Volumes, Prices, Revenues
7.6 Rest of Asia Pacific
7.6.1 Research – Volumes, Prices, Revenues
7.6.2 Clinical  – Volumes, Prices, Revenues
7.6.3 AgriBio– Volumes, Prices, Revenues
7.6.4 Direct to Consumer Testing – Volumes, Prices, Revenues
7.6.5 Tumor – Volumes, Prices, Revenues

8. Country Markets – Latin America, Africa & The Middle East
8.1 Brazil
8.1.1 Research – Volumes, Prices, Revenues
8.1.2 Clinical  – Volumes, Prices, Revenues
8.1.3 AgriBio– Volumes, Prices, Revenues
8.1.4 Direct to Consumer Testing – Volumes, Prices, Revenues
8.1.5 Tumor – Volumes, Prices, Revenues
8.2 Mexico
8.2.1 Research – Volumes, Prices, Revenues
8.2.2 Clinical  – Volumes, Prices, Revenues
8.2.3 AgriBio – Volumes, Prices, Revenues
8.2.4 Direct to Consumer Testing – Volumes, Prices, Revenues
8.2.5 Tumor – Volumes, Prices, Revenues
8.3 Rest of Latin America
8.3.1 Research – Volumes, Prices, Revenues
8.3.2 Clinical  – Volumes, Prices, Revenues
8.3.3 AgriBio – Volumes, Prices, Revenues
8.3.4 Direct to Consumer Testing – Volumes, Prices, Revenues
8.3.5 Tumor – Volumes, Prices, Revenues
8.4 Africa & The Middle East
8.4.1 Research – Volumes, Prices, Revenues
8.4.2 Clinical  – Volumes, Prices, Revenues
8.4.3 AgriBio– Volumes, Prices, Revenues
8.4.4 Direct to Consumer Testing – Volumes, Prices, Revenues
8.4.5 Tumor – Volumes, Prices, Revenues

9. Global Market Summary
9.1 Global Market
9.1.1 Research – Volumes, Prices, Revenues
9.1.2 Clinical  – Volumes, Prices, Revenues
9.1.3 AgriBio – Volumes, Prices, Revenues
9.1.4 Direct to Consumer Testing – Volumes, Prices, Revenues
9.1.5 Tumor – Volumes, Prices, Revenues

10. Vision of the Future of Whole Genome Sequencing

Appendices

I. United States Medicare System: January 2018 laboratory Fees Schedule – National Limit and Midpoint
II Methodology
II.1 Authors
II.2 Sources

Table of Tables

Table 1  The Base Pairs
Table 2 Most Common Traditional Genetic Disorders
Table 3 Medicare Clinical Lab Expenditures Actual & Forecast 2004 to 2020 ($Billion)
Table 4 List of GLOBAL SEQUENCING LOCATIONS
Table 5  Market Players by Type
Table 6 The Different Markets for Whole Genome Sequencing
Table 7 DTC Sub Segments
Table 8  Roles of WGS in AgriBio
Table 9 The Factors Driving Growth
Table 10 Factors Limiting Growth
Table 11 - Listing of Current Instrument Specifications
Table 12 Six New Sequencing Technologies
Table 13 USA Research - Volume Price and Revenue Forecast
Table 14 USA Clinical - Volume Price and Revenue Forecast
Table 15 USA AgriBio - Volume Price and Revenue Forecast
Table 16 USA Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 17 USA Tumor - Volume Price and Revenue Forecast
Table 18 Canada Research - Volume Price and Revenue Forecast
Table 19 Canada Clinical  - Volume Price and Revenue Forecast
Table 20 Canada AgriBio - Volume Price and Revenue Forecast
Table 21 Canada Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 22 Canada Tumor - Volume Price and Revenue Forecast
Table 23 France Research - Volume Price and  Revenue Forecast
Table 24 France Clinical  - Volume Price and Revenue Forecast
Table 25 France AgriBio - Volume Price and Revenue Forecast
Table 26 France Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 27 France Tumor - Volume Price and Revenue Forecast
Table 28 Germany Research - Volume Price and  Revenue Forecast
Table 29 Germany Clinical  - Volume Price and Revenue Forecast
Table 30 Germany AgriBio - Volume Price and  Revenue Forecast
Table 31 Germany Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 32 Germany Tumor - Volume Price and Revenue Forecast
Table 33 U.K. Research - Volume Price and Revenue Forecast
Table 34 U.K. Clinical  - Volume Price and Revenue Forecast
Table 35 U.K. AgriBio - Volume Price and Revenue Forecast
Table 36 U.K. Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 37 U.K. Tumor - Volume Price and Revenue Forecast
Table 38 Spain Research - Volume Price and Revenue Forecast
Table 39 Spain Clinical  - Volume Price and Revenue Forecast
Table 40 Spain AgriBio - Volume Price and Revenue Forecast
Table 41 Spain Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 42 Spain Tumor - Volume Price and Revenue Forecast
Table 43 Italy Research - Volume Price and  Revenue Forecast
Table 44 Italy Clinical  - Volume Price and Revenue Forecast
Table 45 Italy AgriBio - Volume Price and  Revenue Forecast
Table 46 Italy Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 47 Italy Tumor - Volume Price and Revenue Forecast
Table 48 Russia Research - Volume Price and Revenue Forecast
Table 49 Russia Clinical  - Volume Price and Revenue Forecast
Table 50 Russia AgriBio - Volume Price and Revenue Forecast
Table 51 Russia Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 52 Russia Tumor - Volume Price and Revenue Forecast
Table 53 Rest of Europe Research - Volume Price and Revenue Forecast
Table 54 Rest of Europe Clinical  - Volume Price and Revenue Forecast
Table 55 Rest of Europe AgriBio - Volume Price and Revenue Forecast
Table 56 Rest of Europe Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 57 Rest of Europe Tumor - Volume Price and Revenue Forecast
Table 58 China Research - Volume Price and Revenue Forecast
Table 59 China Clinical  - Volume Price and Revenue Forecast
Table 60 China AgriBio - Volume Price and Revenue Forecast
Table 61 China Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 62 China Tumor - Volume Price and Revenue Forecast
Table 63 Japan Research - Volume Price and Revenue Forecast
Table 64 Japan Clinical  - Volume Price and Revenue Forecast
Table 65 Japan AgriBio - Volume Price and Revenue Forecast
Table 66 Japan Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 67 Japan Tumor - Volume Price and Revenue Forecast
Table 68 South Korea Research - Volume Price and  Revenue Forecast
Table 69 South Korea Clinical  - Volume Price and Revenue Forecast
Table 70 South Korea AgriBio - Volume Price and  Revenue Forecast
Table 71 South Korea Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 72 South Korea Tumor - Volume Price and Revenue Forecast
Table 73 India Research - Volume Price and  Revenue Forecast
Table 74 India Clinical  - Volume Price and Revenue Forecast
Table 75 India AgriBio - Volume Price and  Revenue Forecast
Table 76 India Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 77 India Tumor - Volume Price and Revenue Forecast
Table 78 Australia Research - Volume Price and  Revenue Forecast
Table 79 Australia Predictive Testing - Volume Price and Revenue Forecast
Table 80 Australia AgriBio - Volume Price and  Revenue Forecast
Table 81 Australia Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 82 Australia Tumor - Volume Price and Revenue Forecast
Table 83 Rest of Asia Pacific Research - Volume Price and  Revenue Forecast
Table 84 Rest of Asia Pacific Clinical  - Volume Price and Revenue Forecast
Table 85 Rest of Asia Pacific AgriBio- Volume Price and Revenue Forecast
Table 86 Rest of Asia Pacific Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 87 Rest of Asia Pacific Tumor - Volume Price and Revenue Forecast
Table 88 Brazil Research - Volume Price and Revenue Forecast
Table 89 Brazil Clinical  - Volume Price and Revenue Forecast
Table 90 Brazil AgriBio- Volume Price and Revenue Forecast
Table 91 Brazil Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 92 Brazil Tumor - Volume Price and Revenue Forecast
Table 93 Mexico Research - Volume Price and  Revenue Forecast
Table 94 Mexico Clinical  - Volume Price and Revenue Forecast
Table 95 Mexico AgriBio - Volume Price and  Revenue Forecast
Table 96 Mexico Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 97 Mexico Tumor - Volume Price and Revenue Forecast 
Table 98 Rest of Latin America Research - Volume Price and Revenue Forecast
Table 99 Rest of Latin America Clinical  - Volume Price and Revenue Forecast
Table 100 Rest of Latin America AgriBio- Volume Price and  Revenue Forecast
Table 101 Rest of Latin America Direct to Consumer Testing - Volume Price and Revenue Forecast294
Table 102 Rest of Latin America Tumor - Volume Price and Revenue Forecast
Table 103 Africa & Middle East Research - Volume Price and Revenue Forecast
Table 104 Africa & Middle East Clinical  - Volume Price and Revenue Forecast
Table 105 Africa & Middle East AgriBio- Volume Price and Revenue Forecast
Table 106 Africa & Middle East Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 107 Africa & Middle East Tumor - Volume Price and Revenue Forecast
Table 108 Global Research - Volume Price and Revenue Forecast
Table 109 Global Clinical  - Volume Price and Revenue Forecast
Table 110 Global AgriBio - Volume Price and Revenue Forecast
Table 111 Global Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 112 Global Tumor  - Volume Price and Revenue Forecast 
Table 113 2018 Clinical Lab Fee Schedule

Table of Figures

Figure 1 Medicare Clinical Lab Expenditures 2004 to 2020 ($Million)
Figure 2 Size of Genome for Various Species
Figure 3 - Cost To Sequence a Human Genome

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • 10X Genomics
  • 23 and Me
  • Agilent Technologies
  • Ancestry.com
  • BGI Genomics Co. Ltd.
  • Bio-Rad
  • Centogene
  • Complete Genomics - BGI
  • Dante Labs
  • Fabric Genomics
  • GE Global Research
  • Gencove
  • Gene by Gene Ltd
  • Genewiz
  • Genomic Health
  • Genomics England
  • Genomics Personalized Health (GPH)
  • Grail
  • Guardiome
  • Helix
  • Human Longevity, Inc.
  • Illumina
  • Invitae
  • Macrogen
  • Medgenome
  • MNG Labs
  • Novogene
  • Omega Bioservices
  • ORIG3N
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Perkin Elmer
  • Personalis
  • Qiagen
  • Regeneron
  • Roche Molecular Diagnostics
  • Sequencing.com
  • Siemens Healthcare
  • Stratos Genomics
  • Sure Genomics
  • Thermo Fisher
  • Veritas Genetics
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll